Cure My Disease

Don't miss your cure!

 Log in / Sign up

Beetroot juice may boost exercise in lung scarring disease

NCT ID NCT06488638

Recruiting now Symptom relief Sponsor: University Hospital Southampton NHS Foundation Trust Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 07, 2026 · Updated 3 times

Summary

This study investigates whether drinking nitrate-rich beetroot juice twice a day for three days can improve exercise capacity in people with idiopathic pulmonary fibrosis (IPF), a lung scarring disease that limits activity. Researchers will compare the juice to a placebo in a small group of 8 IPF patients and also measure blood markers and blood flow. The goal is to see if this simple supplement can help patients exercise longer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
nitrate-rich beetroot juice
What this could lead to
If it works, this could point toward a simple dietary supplement to help IPF patients exercise more easily.
What could go wrong
This is a very small pilot study with only 8 IPF patients, so results may not apply broadly. The supplement may show no benefit or cause side effects like stomach upset.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

idiopathic pulmonary fibrosis interstitial lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IDIOPATHIC PULMONARY FIBROSIS INTERSTITIAL LUNG DISEASE

Contacts and locations

Locations

  • University Hospital Southampton

    RECRUITING

    Southampton, SO16 6YD, United Kingdom

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.